Current Report Filing (8-k)
April 17 2014 - 4:10PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 17, 2014 (April 16, 2014)
ALEXZA PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
000-51820 |
|
77-0567768 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
|
|
|
Alexza Pharmaceuticals, Inc.
2091 Stierlin Court
Mountain View, California |
|
94043 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (650) 944-7000
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Section 8 Other Events
Item 8.01. Other Events.
On
April 16, 2014, the Board of Directors of Alexza Pharmaceuticals, Inc. (the Company) appointed Mr. Winston R. Brown, Jr. to the position of Vice President, Quality. The Companys press release regarding
Mr. Browns appointment is furnished as Exhibit 99.1 hereto, the contents of which are incorporated herein by reference.
Section 9
Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit Number |
|
Description |
|
|
99.1 |
|
Press Release, dated April 17, 2014, entitled Winston R. Brown, Jr. Joins Alexza Pharmaceuticals as Vice President, Quality. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
ALEXZA PHARMACEUTICALS, INC. |
|
|
|
|
Date: April 17, 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Mark K. Oki |
|
|
|
|
|
|
Mark K. Oki Senior Vice President, Finance
Chief Financial Officer & Secretary |
INDEX TO EXHIBITS
|
|
|
Exhibit Number |
|
Description |
|
|
99.1 |
|
Press Release, dated April 17, 2014, entitled Winston R. Brown, Jr. Joins Alexza Pharmaceuticals as Vice President, Quality. |